We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$53M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$26.7M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$23.7M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$19.5M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15M

Sector Composition

Rank Sector Weight
1 Technology 26.99%
2 Healthcare 10.86%
3 Consumer Discretionary 10.71%
4 Financials 8.62%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EGIS
2226
DELISTED
2ndVote Society Defended ETF
EGIS
$145K ﹤0.01%
+5,011
New +$156K
AMPH icon
2227
Amphastar Pharmaceuticals
AMPH
$857M
$144K ﹤0.01%
5,143
+3,044
+145% +$99.4K
CM icon
2228
Canadian Imperial Bank of Commerce
CM
$112B
$144K ﹤0.01%
3,264
+2,539
+350% +$124K
GUSH icon
2229
Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X ETF
GUSH
$248M
$144K ﹤0.01%
4,484
-108,964
-96% -$4.01M
ADPT icon
2230
Adaptive Biotechnologies
ADPT
$3.91B
$143K ﹤0.01%
20,114
+16,369
+437% +$154K
ARKK icon
2231
ARK Innovation ETF
ARKK
$6.55B
$143K ﹤0.01%
3,781
-4,206
-53% -$187K
BKSY icon
2232
BlackSky Technology
BKSY
$1.27B
$143K ﹤0.01%
11,923
+10,364
+665% +$179K
CRBU icon
2233
Caribou Biosciences
CRBU
$159M
$143K ﹤0.01%
13,557
+10,489
+342% +$97.7K
EWC icon
2234
iShares MSCI Canada ETF
EWC
$6.54B
$143K ﹤0.01%
4,624
+1,525
+49% +$51.9K
FMS icon
2235
Fresenius Medical Care
FMS
$12.6B
$143K ﹤0.01%
10,216
+25
+0.2% +$473
WWW icon
2236
Wolverine World Wide
WWW
$1.62B
$143K ﹤0.01%
9,281
+6,699
+259% +$138K
VGR
2237
DELISTED
Vector Group Ltd.
VGR
$143K ﹤0.01%
16,197
-7,637
-32% -$77.5K
SILK
2238
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$143K ﹤0.01%
3,187
+1,934
+154% +$83.2K
OPTU
2239
Optimum Communications Inc
OPTU
$234M
$142K ﹤0.01%
24,344
+10,028
+70% +$96K
BCC icon
2240
Boise Cascade
BCC
$2.93B
$142K ﹤0.01%
2,385
+912
+62% +$58.7K
BLMN icon
2241
Bloomin' Brands
BLMN
$929M
$142K ﹤0.01%
7,748
+2,861
+59% +$56.9K
CBZ icon
2242
CBIZ
CBZ
$2.96B
$142K ﹤0.01%
3,304
+1,317
+66% +$57.6K
CSTM icon
2243
Constellium
CSTM
$3.95B
$142K ﹤0.01%
13,986
+9,020
+182% +$120K
SRTS icon
2244
Sensus Healthcare
SRTS
$51.9M
$142K ﹤0.01%
11,352
+6,668
+142% +$79.7K
XHR
2245
Xenia Hotels & Resorts
XHR
$1.75B
$142K ﹤0.01%
10,319
+6,411
+164% +$102K
MZZ icon
2246
ProShares UltraShort MidCap400
MZZ
$2.31M
$141K ﹤0.01%
6,502
+494
+8% +$9.12K
TRN icon
2247
Trinity Industries
TRN
$2.33B
$141K ﹤0.01%
6,602
+3,846
+140% +$94.1K
RVNC
2248
DELISTED
Revance Therapeutics, Inc.
RVNC
$141K ﹤0.01%
5,214
+1,831
+54% +$37.1K
GEF icon
2249
Greif
GEF
$5.04B
$140K ﹤0.01%
2,363
-9,282
-80% -$619K
NUVL
2250
DELISTED
Nuvalent
NUVL
$140K ﹤0.01%
7,171
-6,597
-48% -$110K
88 89
90
91 92

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.